# Nanoparticulate Versus Micronized Steroids Delivery for Transdermal Hormone Replacement Therapy

> **NCT02467673** · PHASE2 · COMPLETED · sponsor: **University Potiguar** · enrollment: 185 (actual)

## Conditions studied

- Menopausal Syndrome

## Interventions

- **DRUG:** Micronized estradiol + progesterone
- **DRUG:** Nanoparticulate estradiol + progesterone

## Key facts

- **NCT ID:** NCT02467673
- **Lead sponsor:** University Potiguar
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2012-03
- **Final completion:** 2012-07
- **Target enrollment:** 185 (ACTUAL)
- **Last updated:** 2016-05-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02467673

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02467673, "Nanoparticulate Versus Micronized Steroids Delivery for Transdermal Hormone Replacement Therapy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02467673. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*